Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America

ABSTRACT: The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient access to these therapies. There is currently a need to define and comply...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Ther
Main Authors: Steinberg, Judith, Fragoso, Yara D., Duran Quiroz, Juan Carlos, García, Juan Raul, Guerra, Caroline, Rodriguez, Virginia, Carcamo Rodriguez, Claudia, Ciampi, Ethel, Correa-Diaz, Edgar, Macías, Miguel, Novarro, Nelson, Vizcarra, Darwin, Oehninger Gatti, Carlos, Orozco, Geraldine, Carrá, Adriana
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858893/
https://ncbi.nlm.nih.gov/pubmed/31127566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-019-0139-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados